Hypermarcas (OTCMKTS:HYPMY) Stock Price Passes Below 50-Day Moving Average – What’s Next?

Shares of Hypermarcas (OTCMKTS:HYPMY) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $4.20 and traded as low as $4.16. Hypermarcas shares last traded at $4.16, with a volume of 867 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Hypermarcas Price Performance

The firm has a market cap of $2.93 billion, a P/E ratio of 8.67 and a beta of 0.71. The firm’s 50-day moving average price is $4.20 and its 200 day moving average price is $4.39.

Hypermarcas (OTCMKTS:HYPMY) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The firm had revenue of $383.13 million during the quarter. Analysts forecast that Hypermarcas will post 0.53 earnings per share for the current year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.